Align Summit – Hosted by MassBio

MassBio’s annual early-stage and funder partnering conference, Align Summit, with insights from McKinsey and Locust Walk, builds relationships between funders and biotech startups and small companies by showcasing the best and the brightest in the life sciences.

Through presentations by emerging life sciences companies, thought leadership sessions, and partnering meetings, the 2025 Align Summit will look to a brighter future by focusing on the next generation therapies and the rapidly-expanding promise of techbio.

The application to present at Align Summit is now open until June 20 at 12:00 PM (noon). If your Seed to Series B company fits the criteria outlined below, we encourage you to apply. This year’s presentation tracks are:

• AI/ML-Driven Drug Design, Discovery, Development: This track will highlight companies using artificial intelligence and machine learning (AI/ML) to transform drug discovery and development.
• Next-Generation Multispecific Therapeutics: This track will feature companies focused on cutting-edge advancements in multi-specific therapies, emphasizing their ability to address complex biological pathways and improve targeted delivery mechanisms.
• The Future of Precision Therapies: This track will feature companies focused using precision therapies that customize treatments based on individual genetic, molecular, or biomarker profiles.